Roth, Patrick <br/><br/>
Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti-PD-1 treatment with nivolumab.  [electronic resource] 

 -  Neuro-oncology  03 2017 
 - 454-456 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-5866 
<br/><br/><label>Standard No.: </label>10.1093/neuonc/now265  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Glioblastoma--drug therapy<br/>Humans<br/>Immunotherapy<br/>Middle Aged<br/>Nivolumab--therapeutic use<br/>Prognosis<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Remission Induction